Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 16Carcinoma, Basal Cell 7Liver Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Mesothelioma, Malignant 2Leukoplakia, Oral 2Colorectal Neoplasms 2Cholangiocarcinoma 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Warts 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Signs and Symptoms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Retinoblastoma 1Precancerous Conditions 1Pleural Diseases 1Pituitary Neoplasms 1Pain 1Optic Nerve Glioma 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Neuroectodermal Tumors, Primitive 1

Interventions

Mitomycin 11Gemcitabine 7BCG Vaccine 4Imiquimod 2Administration, Intravesical 2viscum album peptide 1pemigatinib 1pembrolizumab 1erdafitinib 1dodecyl maltoside 1Water 1VPM1002 recombinant BCG vaccine 1VB4-845 1Therapeutics 1Photochemotherapy 1Neoadjuvant Therapy 1Interferon-alpha 1Hyaluronic Acid 1High-Intensity Interval Training 1Gels 1Ethacrynic Acid 1Epirubicin 1Educational Status 1Doxorubicin 1Docetaxel 1Dihematoporphyrin Ether 1Cystoscopy 1Celecoxib 1BCG Connaught 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Non-Muscle Invasive Bladder Neoplasms × Photochemotherapy × Clear all
NCT03053635 2018-08-20

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

TheralaseĀ® Technologies Inc.

Phase 1 Completed
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚔